The Latest Breaking News from BioNTech

The immunologist who runs Scancell is trialling novel treatments to attack tumours, as well as needle-free Covid jabs

Here’s a look at the status of mRNA technology's application in cancer and when it might reach patients.

Top U.N. officials and health industry leaders are trying to tackle an alarming surge in tuberculosis, which is now killing more people worldwide than COVID-19 or AIDS

Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay half price, or about 10 euros ($11), for each of about 70 million cancelled doses, the Financial Times reported on Sunday. The revised contract would allow…

Experts hope new vaccines will be ready by end of decade

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases

Six mobile vaccine-production units developed by German pharmaceutical company BioNTech have arrived in Rwanda. This is the first such shipment to Africa as the continent seeks to boost local production of mRNA vaccines.

Barely a month goes by without headlines announcing yet another advancement in cancer vaccines.

Using the same mRNA technology as COVID vaccines, cancer vaccines are an emerging personalised treatment for cancer.

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

In this crucial area of innovation, established companies and startups must work together to deliver the benefits that the science promises.